Lipid Lowering After Myocardial Infarction: Too Little, Too Late
- PMID: 37879778
- DOI: 10.1016/j.jacc.2023.08.038
Lipid Lowering After Myocardial Infarction: Too Little, Too Late
Keywords: computed tomography angiography; low-density lipoprotein; myocardial infarction; statin.
Conflict of interest statement
Funding Support and Author Disclosures Dr Montalescot has received research funds to his institution or has received consulting/lecture fees from Abbott, Amgen, AstraZeneca, Ascendia, Bayer, BMS, Boehringer Ingelheim, Boston Scientific, Celecor, CSL Behring, Idorsia, Lilly, Novartis, Novo Nordisk, Opalia, Pfizer, Quantum Genomics, Sanofi, and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy.J Am Coll Cardiol. 2023 Oct 31;82(18):1737-1747. doi: 10.1016/j.jacc.2023.08.019. Epub 2023 Aug 26. J Am Coll Cardiol. 2023. PMID: 37640248
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
